lysine has been researched along with gsk2879552 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Acusta, A; Ballas, M; Borthakur, G; Collingwood, T; de la Fuente Burguera, A; Del Buono, H; Dhar, A; Ferron-Brady, G; Karpinich, NO; Kruger, RG; Mohammad, HP; Roboz, GJ; Sanz, G; Verma, A; Wei, AH; Yee, K | 1 |
| Chen, Z; Cho, E; Ding, M; Lee, TH; Park, SW | 1 |
1 trial(s) available for lysine and gsk2879552
| Article | Year |
|---|---|
Phase I trials of the lysine-specific demethylase 1 inhibitor, GSK2879552, as mono- and combination-therapy in relapsed/refractory acute myeloid leukemia or high-risk myelodysplastic syndromes.
Topics: Benzoates; Cyclopropanes; Humans; Leukemia, Myeloid, Acute; Lysine; Myelodysplastic Syndromes | 2022 |
1 other study(ies) available for lysine and gsk2879552
| Article | Year |
|---|---|
Crucial Role of Lysine-Specific Histone Demethylase 1 in RANKL-Mediated Osteoclast Differentiation.
Topics: Bone Resorption; Cell Differentiation; Female; Histone Demethylases; Lysine; Mice; Osteoclasts; Osteogenesis; Osteoporosis; Ovariectomy; RANK Ligand | 2023 |